Assenagon Asset Management’s Ocular Therapeutix OCUL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Sell |
193,700
-148,100
| -43% | -$1.37M | ﹤0.01% | 778 |
|
|
2025
Q1 | $2.51M | Buy |
+341,800
| New | +$2.51M | ﹤0.01% | 672 |
|
|
2024
Q4 | – | Sell |
-2,825,756
| Closed | -$24.6M | – | 1383 |
|
|
2024
Q3 | $24.6M | Buy |
+2,825,756
| New | +$24.6M | 0.05% | 273 |
|
|
2022
Q1 | – | Sell |
-13,694
| Closed | -$95K | – | 1468 |
|
|
2021
Q4 | $95K | Sell |
13,694
-5,903
| -30% | -$41K | ﹤0.01% | 1351 |
|
|
2021
Q3 | $196K | Sell |
19,597
-77,417
| -80% | -$774K | ﹤0.01% | 1196 |
|
|
2021
Q2 | $1.38M | Buy |
97,014
+1,119
| +1% | +$15.9K | ﹤0.01% | 784 |
|
|
2021
Q1 | $1.57M | Hold |
95,895
| – | – | 0.01% | 743 |
|
|
2020
Q4 | $1.99M | Buy |
+95,895
| New | +$1.99M | 0.01% | 497 |
|